BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 10347229)

  • 1. Cbl-mediated negative regulation of platelet-derived growth factor receptor-dependent cell proliferation. A critical role for Cbl tyrosine kinase-binding domain.
    Miyake S; Mullane-Robinson KP; Lill NL; Douillard P; Band H
    J Biol Chem; 1999 Jun; 274(23):16619-28. PubMed ID: 10347229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity.
    Bonita DP; Miyake S; Lupher ML; Langdon WY; Band H
    Mol Cell Biol; 1997 Aug; 17(8):4597-610. PubMed ID: 9234717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor alpha.
    Miyake S; Lupher ML; Druker B; Band H
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):7927-32. PubMed ID: 9653117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor.
    Lill NL; Douillard P; Awwad RA; Ota S; Lupher ML; Miyake S; Meissner-Lula N; Hsu VW; Band H
    J Biol Chem; 2000 Jan; 275(1):367-77. PubMed ID: 10617627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor β (PDGFRβ) Internalization and Signaling.
    Rorsman C; Tsioumpekou M; Heldin CH; Lennartsson J
    J Biol Chem; 2016 May; 291(22):11608-18. PubMed ID: 27048651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis.
    Yokouchi M; Wakioka T; Sakamoto H; Yasukawa H; Ohtsuka S; Sasaki A; Ohtsubo M; Valius M; Inoue A; Komiya S; Yoshimura A
    Oncogene; 1999 Jan; 18(3):759-67. PubMed ID: 9989826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low density lipoprotein receptor-related protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the platelet-derived growth factor receptor beta (PDGFR beta).
    Takayama Y; May P; Anderson RG; Herz J
    J Biol Chem; 2005 May; 280(18):18504-10. PubMed ID: 15753096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histidine-domain-containing protein tyrosine phosphatase regulates platelet-derived growth factor receptor intracellular sorting and degradation.
    Ma H; Wardega P; Mazaud D; Klosowska-Wardega A; Jurek A; Engström U; Lennartsson J; Heldin CH
    Cell Signal; 2015 Nov; 27(11):2209-19. PubMed ID: 26232618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase.
    Ota S; Hazeki K; Rao N; Lupher ML; Andoniou CE; Druker B; Band H
    J Biol Chem; 2000 Jan; 275(1):414-22. PubMed ID: 10617633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323.
    Lupher ML; Rao N; Lill NL; Andoniou CE; Miyake S; Clark EA; Druker B; Band H
    J Biol Chem; 1998 Dec; 273(52):35273-81. PubMed ID: 9857068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
    Bowtell DD; Langdon WY
    Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.
    Taher TE; Tjin EP; Beuling EA; Borst J; Spaargaren M; Pals ST
    J Immunol; 2002 Oct; 169(7):3793-800. PubMed ID: 12244174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cbl on ZAP-70 in T cells.
    Rao N; Lupher ML; Ota S; Reedquist KA; Druker BJ; Band H
    J Immunol; 2000 May; 164(9):4616-26. PubMed ID: 10779765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7.
    Yokouchi M; Kondo T; Houghton A; Bartkiewicz M; Horne WC; Zhang H; Yoshimura A; Baron R
    J Biol Chem; 1999 Oct; 274(44):31707-12. PubMed ID: 10531381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological function of PDGF-induced PI-3 kinase activity: its role in alpha PDGF receptor-mediated mitogenic signaling.
    Yu JC; Gutkind JS; Mahadevan D; Li W; Meyers KA; Pierce JH; Heidaran MA
    J Cell Biol; 1994 Oct; 127(2):479-87. PubMed ID: 7929590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proto-oncogene c-Cbl is a negative regulator of DNA synthesis initiated by both receptor and cytoplasmic tyrosine kinases.
    Broome MA; Galisteo ML; Schlessinger J; Courtneidge SA
    Oncogene; 1999 May; 18(18):2908-12. PubMed ID: 10362262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-derived growth factor (PDGF) stimulates glucose transport in 3T3-L1 adipocytes overexpressing PDGF receptor by a pathway independent of insulin receptor substrates.
    Whiteman EL; Chen JJ; Birnbaum MJ
    Endocrinology; 2003 Sep; 144(9):3811-20. PubMed ID: 12933652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of Cbl to a phospholipase Cgamma1-docking site on platelet-derived growth factor receptor beta provides a dual mechanism of negative regulation.
    Reddi AL; Ying G; Duan L; Chen G; Dimri M; Douillard P; Druker BJ; Naramura M; Band V; Band H
    J Biol Chem; 2007 Oct; 282(40):29336-47. PubMed ID: 17620338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain.
    Yankee TM; Keshvara LM; Sawasdikosol S; Harrison ML; Geahlen RL
    J Immunol; 1999 Dec; 163(11):5827-35. PubMed ID: 10570266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation.
    Andoniou CE; Lill NL; Thien CB; Lupher ML; Ota S; Bowtell DD; Scaife RM; Langdon WY; Band H
    Mol Cell Biol; 2000 Feb; 20(3):851-67. PubMed ID: 10629042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.